Company & Sponsor Intelligence
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed6
Countries1
Therapeutic footprint
autismdepressionout_of_scope
Indexed studies
NCT00065962Secretin for the Treatment of Autism
autism · United StatesPHASE3
autism · United StatesPHASE3
NCT00999778Optimizing Social and Communication Outcomes for Toddlers With Autism
autism · United StatesNA
autism · United StatesNA
NCT00597948Healthy Lifestyles for People With Intellectual Disabilities
autism · United StatesNA
autism · United StatesNA
NCT00965068Cholesterol in ASD: Characterization and Treatment
autism · United StatesPHASE1, PHASE2
autism · United StatesPHASE1, PHASE2
NCT00001180Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
out_of_scope · United StatesCOMPLETED
out_of_scope · United StatesCOMPLETED
NCT00044174Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants
depression · United StatesCOMPLETED
depression · United StatesCOMPLETED
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →